BPC-157 side effects in dogs: what is and is not known
What the research says about BPC-157 risks, the gaps in the safety data and the product quality problems UK owners should know about.
By The Puptides Desk. Updated 2026-11-13.

Sellers tend to describe BPC-157 as having no side effects. The evidence does not support a statement that confident.
What studies report
Short studies in rats and mice have generally not reported serious harm. They were small, brief and not designed to find rare or long-term effects.
What nobody has studied
- Long-term use in any species
- Safety in dogs specifically
- Use in puppies, pregnant dogs or dogs with cancer
- Interactions with common veterinary medicines
Open questions
BPC-157 seems to affect the growth of new blood vessels in animal models. Researchers have asked what that might mean for dogs with tumours. The question is unanswered.
The risk people forget: the product
Unregulated products can contain the wrong amount, impurities or contamination. Injectable products carry extra risk if they are not sterile. A batch certificate from a named lab reduces this risk. A purity figure on a website does not. See how to check a brand.
Signs to take seriously
If a dog has been given any unlicensed product and shows swelling, lethargy, vomiting, loss of appetite or a reaction at an injection site, contact your vet promptly and tell them exactly what was given.
Bottom line
Absence of evidence of harm is not evidence of safety. Talk to your vet before anything else.
Related: BPC-157 for dogs: the complete UK guide
Read next
- BPC-157 for dogs: the complete UK guide
- Dog peptides, explained without the hype
- BPC-157 for dogs: what does the research actually show?
- Are dog peptides legal in the UK?
- Dog peptide brands ranked for UK buyers